nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC3—Ezetimibe—atherosclerosis	0.106	0.163	CbGbCtD
Lamivudine—ABCC4—Rosuvastatin—atherosclerosis	0.0808	0.125	CbGbCtD
Lamivudine—ABCC1—Rosuvastatin—atherosclerosis	0.065	0.1	CbGbCtD
Lamivudine—ABCC2—Ezetimibe—atherosclerosis	0.0481	0.0741	CbGbCtD
Lamivudine—ABCC2—Simvastatin—atherosclerosis	0.0447	0.0689	CbGbCtD
Lamivudine—ABCC2—Lovastatin—atherosclerosis	0.0437	0.0674	CbGbCtD
Lamivudine—ABCC2—Pravastatin—atherosclerosis	0.0437	0.0674	CbGbCtD
Lamivudine—ABCG2—Rosuvastatin—atherosclerosis	0.0435	0.067	CbGbCtD
Lamivudine—ABCG2—Ezetimibe—atherosclerosis	0.0435	0.067	CbGbCtD
Lamivudine—ABCG2—Pravastatin—atherosclerosis	0.0395	0.0609	CbGbCtD
Lamivudine—SLC22A6—Pravastatin—atherosclerosis	0.032	0.0493	CbGbCtD
Lamivudine—ABCB1—Ezetimibe—atherosclerosis	0.0157	0.0242	CbGbCtD
Lamivudine—ABCB1—Simvastatin—atherosclerosis	0.0146	0.0225	CbGbCtD
Lamivudine—ABCB1—Lovastatin—atherosclerosis	0.0143	0.022	CbGbCtD
Lamivudine—ABCB1—Pravastatin—atherosclerosis	0.0143	0.022	CbGbCtD
Lamivudine—PGK1—connective tissue—atherosclerosis	0.00331	0.0798	CbGeAlD
Lamivudine—PCYT1A—connective tissue—atherosclerosis	0.00262	0.0632	CbGeAlD
Lamivudine—PCYT1A—cardiovascular system—atherosclerosis	0.00228	0.055	CbGeAlD
Lamivudine—NT5C—adipose tissue—atherosclerosis	0.00215	0.0517	CbGeAlD
Lamivudine—PCYT2—liver—atherosclerosis	0.00207	0.05	CbGeAlD
Lamivudine—PGK1—liver—atherosclerosis	0.00178	0.043	CbGeAlD
Lamivudine—NME1—connective tissue—atherosclerosis	0.00175	0.0423	CbGeAlD
Lamivudine—CMPK1—connective tissue—atherosclerosis	0.00169	0.0408	CbGeAlD
Lamivudine—NME1-NME2—liver—atherosclerosis	0.00162	0.0391	CbGeAlD
Lamivudine—NME1—cardiovascular system—atherosclerosis	0.00153	0.0368	CbGeAlD
Lamivudine—NT5C—liver—atherosclerosis	0.0015	0.0363	CbGeAlD
Lamivudine—CMPK1—cardiovascular system—atherosclerosis	0.00147	0.0355	CbGeAlD
Lamivudine—NME2—cardiovascular system—atherosclerosis	0.00144	0.0347	CbGeAlD
Lamivudine—PCYT1A—liver—atherosclerosis	0.00141	0.034	CbGeAlD
Lamivudine—NME1—adipose tissue—atherosclerosis	0.00135	0.0324	CbGeAlD
Lamivudine—CMPK1—adipose tissue—atherosclerosis	0.0013	0.0313	CbGeAlD
Lamivudine—NME2—adipose tissue—atherosclerosis	0.00127	0.0306	CbGeAlD
Lamivudine—NME1—liver—atherosclerosis	0.000944	0.0228	CbGeAlD
Lamivudine—CMPK1—liver—atherosclerosis	0.00091	0.0219	CbGeAlD
Lamivudine—NME2—liver—atherosclerosis	0.000889	0.0214	CbGeAlD
Lamivudine—NME1—Lovastatin—Simvastatin—atherosclerosis	0.000816	0.158	CbGdCrCtD
Lamivudine—NME1—Lovastatin—Pravastatin—atherosclerosis	0.000816	0.158	CbGdCrCtD
Lamivudine—NME1—Fluvastatin—Rosuvastatin—atherosclerosis	0.0007	0.136	CbGdCrCtD
Lamivudine—SLC22A3—connective tissue—atherosclerosis	0.000686	0.0165	CbGeAlD
Lamivudine—NME1—Simvastatin—Pravastatin—atherosclerosis	0.000669	0.13	CbGdCrCtD
Lamivudine—NME1—Simvastatin—Lovastatin—atherosclerosis	0.000669	0.13	CbGdCrCtD
Lamivudine—DCK—adipose tissue—atherosclerosis	0.000646	0.0156	CbGeAlD
Lamivudine—ABCC3—adipose tissue—atherosclerosis	0.000618	0.0149	CbGeAlD
Lamivudine—NME1—Pitavastatin—Rosuvastatin—atherosclerosis	0.000571	0.111	CbGdCrCtD
Lamivudine—SLC22A1—adipose tissue—atherosclerosis	0.000551	0.0133	CbGeAlD
Lamivudine—SLC22A3—adipose tissue—atherosclerosis	0.000527	0.0127	CbGeAlD
Lamivudine—ABCC4—adipose tissue—atherosclerosis	0.000511	0.0123	CbGeAlD
Lamivudine—DCK—Simvastatin—Pravastatin—atherosclerosis	0.000455	0.0884	CbGdCrCtD
Lamivudine—DCK—Simvastatin—Lovastatin—atherosclerosis	0.000455	0.0884	CbGdCrCtD
Lamivudine—DCK—liver—atherosclerosis	0.000453	0.0109	CbGeAlD
Lamivudine—ABCB1—blood vessel—atherosclerosis	0.000452	0.0109	CbGeAlD
Lamivudine—ABCC1—adipose tissue—atherosclerosis	0.000435	0.0105	CbGeAlD
Lamivudine—ABCC3—liver—atherosclerosis	0.000434	0.0105	CbGeAlD
Lamivudine—SLC22A1—liver—atherosclerosis	0.000386	0.00931	CbGeAlD
Lamivudine—SLC22A3—liver—atherosclerosis	0.000369	0.0089	CbGeAlD
Lamivudine—ABCG2—adipose tissue—atherosclerosis	0.00036	0.00869	CbGeAlD
Lamivudine—ABCC4—liver—atherosclerosis	0.000358	0.00863	CbGeAlD
Lamivudine—ABCC2—liver—atherosclerosis	0.000347	0.00835	CbGeAlD
Lamivudine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000345	0.00198	CcSEcCtD
Lamivudine—Tremor—Lovastatin—atherosclerosis	0.000343	0.00197	CcSEcCtD
Lamivudine—Erythema—Simvastatin—atherosclerosis	0.000342	0.00196	CcSEcCtD
Lamivudine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000339	0.00195	CcSEcCtD
Lamivudine—Flatulence—Simvastatin—atherosclerosis	0.000337	0.00193	CcSEcCtD
Lamivudine—Erythema multiforme—Pravastatin—atherosclerosis	0.000336	0.00193	CcSEcCtD
Lamivudine—Dysgeusia—Simvastatin—atherosclerosis	0.000335	0.00192	CcSEcCtD
Lamivudine—Angioedema—Lovastatin—atherosclerosis	0.000334	0.00192	CcSEcCtD
Lamivudine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000333	0.00191	CcSEcCtD
Lamivudine—Anaemia—Ezetimibe—atherosclerosis	0.000332	0.0019	CcSEcCtD
Lamivudine—Malaise—Lovastatin—atherosclerosis	0.00033	0.00189	CcSEcCtD
Lamivudine—Muscle spasms—Simvastatin—atherosclerosis	0.000329	0.00189	CcSEcCtD
Lamivudine—Vertigo—Lovastatin—atherosclerosis	0.000329	0.00189	CcSEcCtD
Lamivudine—Angioedema—Ezetimibe—atherosclerosis	0.000328	0.00188	CcSEcCtD
Lamivudine—Leukopenia—Lovastatin—atherosclerosis	0.000327	0.00188	CcSEcCtD
Lamivudine—Chills—Niacin—atherosclerosis	0.000324	0.00186	CcSEcCtD
Lamivudine—Malaise—Ezetimibe—atherosclerosis	0.000324	0.00186	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000321	0.00184	CcSEcCtD
Lamivudine—Tremor—Simvastatin—atherosclerosis	0.000321	0.00184	CcSEcCtD
Lamivudine—Alopecia—Niacin—atherosclerosis	0.000319	0.00183	CcSEcCtD
Lamivudine—Chills—Pravastatin—atherosclerosis	0.000319	0.00183	CcSEcCtD
Lamivudine—Insomnia—Rosuvastatin—atherosclerosis	0.000319	0.00183	CcSEcCtD
Lamivudine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000317	0.00182	CcSEcCtD
Lamivudine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000316	0.00182	CcSEcCtD
Lamivudine—Anaemia—Simvastatin—atherosclerosis	0.000316	0.00181	CcSEcCtD
Lamivudine—Malnutrition—Niacin—atherosclerosis	0.000314	0.0018	CcSEcCtD
Lamivudine—Erythema—Niacin—atherosclerosis	0.000314	0.0018	CcSEcCtD
Lamivudine—Alopecia—Pravastatin—atherosclerosis	0.000314	0.0018	CcSEcCtD
Lamivudine—Cough—Ezetimibe—atherosclerosis	0.000313	0.0018	CcSEcCtD
Lamivudine—Angioedema—Simvastatin—atherosclerosis	0.000313	0.00179	CcSEcCtD
Lamivudine—Arthralgia—Lovastatin—atherosclerosis	0.000311	0.00179	CcSEcCtD
Lamivudine—Myalgia—Lovastatin—atherosclerosis	0.000311	0.00179	CcSEcCtD
Lamivudine—Chest pain—Lovastatin—atherosclerosis	0.000311	0.00179	CcSEcCtD
Lamivudine—Anxiety—Lovastatin—atherosclerosis	0.00031	0.00178	CcSEcCtD
Lamivudine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00031	0.00178	CcSEcCtD
Lamivudine—Flatulence—Niacin—atherosclerosis	0.00031	0.00178	CcSEcCtD
Lamivudine—Malaise—Simvastatin—atherosclerosis	0.000309	0.00177	CcSEcCtD
Lamivudine—Tension—Niacin—atherosclerosis	0.000308	0.00177	CcSEcCtD
Lamivudine—Discomfort—Lovastatin—atherosclerosis	0.000308	0.00177	CcSEcCtD
Lamivudine—Vertigo—Simvastatin—atherosclerosis	0.000307	0.00176	CcSEcCtD
Lamivudine—Leukopenia—Simvastatin—atherosclerosis	0.000306	0.00176	CcSEcCtD
Lamivudine—Myalgia—Ezetimibe—atherosclerosis	0.000305	0.00175	CcSEcCtD
Lamivudine—Chest pain—Ezetimibe—atherosclerosis	0.000305	0.00175	CcSEcCtD
Lamivudine—Arthralgia—Ezetimibe—atherosclerosis	0.000305	0.00175	CcSEcCtD
Lamivudine—ABCC1—liver—atherosclerosis	0.000305	0.00736	CbGeAlD
Lamivudine—Nervousness—Niacin—atherosclerosis	0.000305	0.00175	CcSEcCtD
Lamivudine—Flatulence—Pravastatin—atherosclerosis	0.000305	0.00175	CcSEcCtD
Lamivudine—Dry mouth—Lovastatin—atherosclerosis	0.000305	0.00175	CcSEcCtD
Lamivudine—Tension—Pravastatin—atherosclerosis	0.000304	0.00174	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000303	0.00174	CcSEcCtD
Lamivudine—Dysgeusia—Pravastatin—atherosclerosis	0.000303	0.00174	CcSEcCtD
Lamivudine—Muscle spasms—Niacin—atherosclerosis	0.000302	0.00173	CcSEcCtD
Lamivudine—Discomfort—Ezetimibe—atherosclerosis	0.000302	0.00173	CcSEcCtD
Lamivudine—Pain—Rosuvastatin—atherosclerosis	0.000301	0.00173	CcSEcCtD
Lamivudine—Constipation—Rosuvastatin—atherosclerosis	0.000301	0.00173	CcSEcCtD
Lamivudine—Confusional state—Lovastatin—atherosclerosis	0.000301	0.00173	CcSEcCtD
Lamivudine—Nervousness—Pravastatin—atherosclerosis	0.0003	0.00172	CcSEcCtD
Lamivudine—Dry mouth—Ezetimibe—atherosclerosis	0.000299	0.00171	CcSEcCtD
Lamivudine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000299	0.00171	CcSEcCtD
Lamivudine—Muscle spasms—Pravastatin—atherosclerosis	0.000297	0.00171	CcSEcCtD
Lamivudine—Infection—Lovastatin—atherosclerosis	0.000297	0.0017	CcSEcCtD
Lamivudine—Confusional state—Ezetimibe—atherosclerosis	0.000295	0.00169	CcSEcCtD
Lamivudine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000293	0.00168	CcSEcCtD
Lamivudine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000292	0.00168	CcSEcCtD
Lamivudine—Arthralgia—Simvastatin—atherosclerosis	0.000291	0.00167	CcSEcCtD
Lamivudine—Chest pain—Simvastatin—atherosclerosis	0.000291	0.00167	CcSEcCtD
Lamivudine—Myalgia—Simvastatin—atherosclerosis	0.000291	0.00167	CcSEcCtD
Lamivudine—Infection—Ezetimibe—atherosclerosis	0.000291	0.00167	CcSEcCtD
Lamivudine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00029	0.00167	CcSEcCtD
Lamivudine—Anxiety—Simvastatin—atherosclerosis	0.00029	0.00167	CcSEcCtD
Lamivudine—Tremor—Pravastatin—atherosclerosis	0.00029	0.00166	CcSEcCtD
Lamivudine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000288	0.00165	CcSEcCtD
Lamivudine—Discomfort—Simvastatin—atherosclerosis	0.000288	0.00165	CcSEcCtD
Lamivudine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000287	0.00165	CcSEcCtD
Lamivudine—Angioedema—Niacin—atherosclerosis	0.000287	0.00165	CcSEcCtD
Lamivudine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000287	0.00165	CcSEcCtD
Lamivudine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000287	0.00165	CcSEcCtD
Lamivudine—Anaemia—Pravastatin—atherosclerosis	0.000286	0.00164	CcSEcCtD
Lamivudine—Anorexia—Lovastatin—atherosclerosis	0.000285	0.00163	CcSEcCtD
Lamivudine—Skin disorder—Ezetimibe—atherosclerosis	0.000284	0.00163	CcSEcCtD
Lamivudine—Angioedema—Pravastatin—atherosclerosis	0.000283	0.00162	CcSEcCtD
Lamivudine—Vertigo—Niacin—atherosclerosis	0.000282	0.00162	CcSEcCtD
Lamivudine—Syncope—Niacin—atherosclerosis	0.000282	0.00162	CcSEcCtD
Lamivudine—Confusional state—Simvastatin—atherosclerosis	0.000282	0.00162	CcSEcCtD
Lamivudine—Leukopenia—Niacin—atherosclerosis	0.000281	0.00161	CcSEcCtD
Lamivudine—Urticaria—Rosuvastatin—atherosclerosis	0.00028	0.00161	CcSEcCtD
Lamivudine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000279	0.0016	CcSEcCtD
Lamivudine—Oedema—Simvastatin—atherosclerosis	0.000279	0.0016	CcSEcCtD
Lamivudine—Malaise—Pravastatin—atherosclerosis	0.000279	0.0016	CcSEcCtD
Lamivudine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000279	0.0016	CcSEcCtD
Lamivudine—Vertigo—Pravastatin—atherosclerosis	0.000278	0.00159	CcSEcCtD
Lamivudine—Infection—Simvastatin—atherosclerosis	0.000277	0.00159	CcSEcCtD
Lamivudine—Leukopenia—Pravastatin—atherosclerosis	0.000277	0.00159	CcSEcCtD
Lamivudine—Loss of consciousness—Niacin—atherosclerosis	0.000276	0.00158	CcSEcCtD
Lamivudine—Cough—Niacin—atherosclerosis	0.000274	0.00157	CcSEcCtD
Lamivudine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000273	0.00157	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000272	0.00156	CcSEcCtD
Lamivudine—Insomnia—Lovastatin—atherosclerosis	0.00027	0.00155	CcSEcCtD
Lamivudine—Cough—Pravastatin—atherosclerosis	0.00027	0.00155	CcSEcCtD
Lamivudine—Paraesthesia—Lovastatin—atherosclerosis	0.000268	0.00154	CcSEcCtD
Lamivudine—Arthralgia—Niacin—atherosclerosis	0.000267	0.00153	CcSEcCtD
Lamivudine—Myalgia—Niacin—atherosclerosis	0.000267	0.00153	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000267	0.00153	CcSEcCtD
Lamivudine—Anorexia—Simvastatin—atherosclerosis	0.000266	0.00153	CcSEcCtD
Lamivudine—Dyspnoea—Lovastatin—atherosclerosis	0.000266	0.00153	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000266	0.00152	CcSEcCtD
Lamivudine—Insomnia—Ezetimibe—atherosclerosis	0.000265	0.00152	CcSEcCtD
Lamivudine—Chest pain—Pravastatin—atherosclerosis	0.000263	0.00151	CcSEcCtD
Lamivudine—Myalgia—Pravastatin—atherosclerosis	0.000263	0.00151	CcSEcCtD
Lamivudine—Arthralgia—Pravastatin—atherosclerosis	0.000263	0.00151	CcSEcCtD
Lamivudine—Paraesthesia—Ezetimibe—atherosclerosis	0.000263	0.00151	CcSEcCtD
Lamivudine—Dyspepsia—Lovastatin—atherosclerosis	0.000263	0.00151	CcSEcCtD
Lamivudine—Anxiety—Pravastatin—atherosclerosis	0.000262	0.00151	CcSEcCtD
Lamivudine—Dry mouth—Niacin—atherosclerosis	0.000262	0.0015	CcSEcCtD
Lamivudine—Dyspnoea—Ezetimibe—atherosclerosis	0.000261	0.0015	CcSEcCtD
Lamivudine—Discomfort—Pravastatin—atherosclerosis	0.00026	0.00149	CcSEcCtD
Lamivudine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00026	0.00149	CcSEcCtD
Lamivudine—Decreased appetite—Lovastatin—atherosclerosis	0.00026	0.00149	CcSEcCtD
Lamivudine—Dyspepsia—Ezetimibe—atherosclerosis	0.000258	0.00148	CcSEcCtD
Lamivudine—Fatigue—Lovastatin—atherosclerosis	0.000257	0.00148	CcSEcCtD
Lamivudine—Oedema—Niacin—atherosclerosis	0.000256	0.00147	CcSEcCtD
Lamivudine—Anaphylactic shock—Niacin—atherosclerosis	0.000256	0.00147	CcSEcCtD
Lamivudine—Pain—Lovastatin—atherosclerosis	0.000255	0.00147	CcSEcCtD
Lamivudine—Constipation—Lovastatin—atherosclerosis	0.000255	0.00147	CcSEcCtD
Lamivudine—Confusional state—Pravastatin—atherosclerosis	0.000255	0.00146	CcSEcCtD
Lamivudine—Decreased appetite—Ezetimibe—atherosclerosis	0.000255	0.00146	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000254	0.00146	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000253	0.00145	CcSEcCtD
Lamivudine—Asthenia—Rosuvastatin—atherosclerosis	0.000253	0.00145	CcSEcCtD
Lamivudine—ABCG2—liver—atherosclerosis	0.000253	0.00609	CbGeAlD
Lamivudine—Insomnia—Simvastatin—atherosclerosis	0.000253	0.00145	CcSEcCtD
Lamivudine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000252	0.00145	CcSEcCtD
Lamivudine—Oedema—Pravastatin—atherosclerosis	0.000252	0.00145	CcSEcCtD
Lamivudine—Fatigue—Ezetimibe—atherosclerosis	0.000252	0.00145	CcSEcCtD
Lamivudine—Shock—Niacin—atherosclerosis	0.000252	0.00145	CcSEcCtD
Lamivudine—Infection—Pravastatin—atherosclerosis	0.000251	0.00144	CcSEcCtD
Lamivudine—Paraesthesia—Simvastatin—atherosclerosis	0.000251	0.00144	CcSEcCtD
Lamivudine—Pain—Ezetimibe—atherosclerosis	0.00025	0.00144	CcSEcCtD
Lamivudine—Constipation—Ezetimibe—atherosclerosis	0.00025	0.00144	CcSEcCtD
Lamivudine—Pruritus—Rosuvastatin—atherosclerosis	0.000249	0.00143	CcSEcCtD
Lamivudine—Skin disorder—Niacin—atherosclerosis	0.000249	0.00143	CcSEcCtD
Lamivudine—Dyspnoea—Simvastatin—atherosclerosis	0.000249	0.00143	CcSEcCtD
Lamivudine—Hyperhidrosis—Niacin—atherosclerosis	0.000248	0.00142	CcSEcCtD
Lamivudine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000247	0.00142	CcSEcCtD
Lamivudine—Feeling abnormal—Lovastatin—atherosclerosis	0.000246	0.00141	CcSEcCtD
Lamivudine—Dyspepsia—Simvastatin—atherosclerosis	0.000246	0.00141	CcSEcCtD
Lamivudine—Anorexia—Niacin—atherosclerosis	0.000244	0.0014	CcSEcCtD
Lamivudine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000244	0.0014	CcSEcCtD
Lamivudine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000244	0.0014	CcSEcCtD
Lamivudine—Decreased appetite—Simvastatin—atherosclerosis	0.000243	0.00139	CcSEcCtD
Lamivudine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000241	0.00138	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000241	0.00138	CcSEcCtD
Lamivudine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000241	0.00138	CcSEcCtD
Lamivudine—Fatigue—Simvastatin—atherosclerosis	0.000241	0.00138	CcSEcCtD
Lamivudine—Anorexia—Pravastatin—atherosclerosis	0.000241	0.00138	CcSEcCtD
Lamivudine—Hypotension—Niacin—atherosclerosis	0.00024	0.00137	CcSEcCtD
Lamivudine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000239	0.00137	CcSEcCtD
Lamivudine—Pain—Simvastatin—atherosclerosis	0.000239	0.00137	CcSEcCtD
Lamivudine—Constipation—Simvastatin—atherosclerosis	0.000239	0.00137	CcSEcCtD
Lamivudine—Urticaria—Lovastatin—atherosclerosis	0.000237	0.00136	CcSEcCtD
Lamivudine—Body temperature increased—Lovastatin—atherosclerosis	0.000236	0.00135	CcSEcCtD
Lamivudine—Abdominal pain—Lovastatin—atherosclerosis	0.000236	0.00135	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000234	0.00134	CcSEcCtD
Lamivudine—Dizziness—Rosuvastatin—atherosclerosis	0.000233	0.00134	CcSEcCtD
Lamivudine—Urticaria—Ezetimibe—atherosclerosis	0.000233	0.00133	CcSEcCtD
Lamivudine—Insomnia—Niacin—atherosclerosis	0.000232	0.00133	CcSEcCtD
Lamivudine—Body temperature increased—Ezetimibe—atherosclerosis	0.000231	0.00133	CcSEcCtD
Lamivudine—Abdominal pain—Ezetimibe—atherosclerosis	0.000231	0.00133	CcSEcCtD
Lamivudine—Paraesthesia—Niacin—atherosclerosis	0.00023	0.00132	CcSEcCtD
Lamivudine—Feeling abnormal—Simvastatin—atherosclerosis	0.00023	0.00132	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00023	0.00132	CcSEcCtD
Lamivudine—Dyspnoea—Niacin—atherosclerosis	0.000229	0.00131	CcSEcCtD
Lamivudine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000228	0.00131	CcSEcCtD
Lamivudine—Insomnia—Pravastatin—atherosclerosis	0.000228	0.00131	CcSEcCtD
Lamivudine—Somnolence—Niacin—atherosclerosis	0.000228	0.00131	CcSEcCtD
Lamivudine—Paraesthesia—Pravastatin—atherosclerosis	0.000227	0.0013	CcSEcCtD
Lamivudine—Dyspepsia—Niacin—atherosclerosis	0.000226	0.0013	CcSEcCtD
Lamivudine—Dyspnoea—Pravastatin—atherosclerosis	0.000225	0.00129	CcSEcCtD
Lamivudine—Decreased appetite—Niacin—atherosclerosis	0.000223	0.00128	CcSEcCtD
Lamivudine—Dyspepsia—Pravastatin—atherosclerosis	0.000222	0.00128	CcSEcCtD
Lamivudine—Rash—Rosuvastatin—atherosclerosis	0.000222	0.00127	CcSEcCtD
Lamivudine—Dermatitis—Rosuvastatin—atherosclerosis	0.000222	0.00127	CcSEcCtD
Lamivudine—Urticaria—Simvastatin—atherosclerosis	0.000222	0.00127	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000221	0.00127	CcSEcCtD
Lamivudine—Abdominal pain—Simvastatin—atherosclerosis	0.000221	0.00127	CcSEcCtD
Lamivudine—Body temperature increased—Simvastatin—atherosclerosis	0.000221	0.00127	CcSEcCtD
Lamivudine—Headache—Rosuvastatin—atherosclerosis	0.000221	0.00127	CcSEcCtD
Lamivudine—Hypersensitivity—Lovastatin—atherosclerosis	0.00022	0.00126	CcSEcCtD
Lamivudine—Decreased appetite—Pravastatin—atherosclerosis	0.000219	0.00126	CcSEcCtD
Lamivudine—Pain—Niacin—atherosclerosis	0.000219	0.00126	CcSEcCtD
Lamivudine—Fatigue—Pravastatin—atherosclerosis	0.000218	0.00125	CcSEcCtD
Lamivudine—Constipation—Pravastatin—atherosclerosis	0.000216	0.00124	CcSEcCtD
Lamivudine—Pain—Pravastatin—atherosclerosis	0.000216	0.00124	CcSEcCtD
Lamivudine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000216	0.00124	CcSEcCtD
Lamivudine—Asthenia—Lovastatin—atherosclerosis	0.000214	0.00123	CcSEcCtD
Lamivudine—Pruritus—Lovastatin—atherosclerosis	0.000211	0.00121	CcSEcCtD
Lamivudine—Asthenia—Ezetimibe—atherosclerosis	0.00021	0.00121	CcSEcCtD
Lamivudine—Gastrointestinal pain—Niacin—atherosclerosis	0.00021	0.0012	CcSEcCtD
Lamivudine—Nausea—Rosuvastatin—atherosclerosis	0.000209	0.0012	CcSEcCtD
Lamivudine—Feeling abnormal—Pravastatin—atherosclerosis	0.000208	0.00119	CcSEcCtD
Lamivudine—Pruritus—Ezetimibe—atherosclerosis	0.000207	0.00119	CcSEcCtD
Lamivudine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000206	0.00118	CcSEcCtD
Lamivudine—Hypersensitivity—Simvastatin—atherosclerosis	0.000206	0.00118	CcSEcCtD
Lamivudine—Diarrhoea—Lovastatin—atherosclerosis	0.000204	0.00117	CcSEcCtD
Lamivudine—Urticaria—Niacin—atherosclerosis	0.000204	0.00117	CcSEcCtD
Lamivudine—Abdominal pain—Niacin—atherosclerosis	0.000203	0.00116	CcSEcCtD
Lamivudine—Body temperature increased—Niacin—atherosclerosis	0.000203	0.00116	CcSEcCtD
Lamivudine—ABCB1—cardiovascular system—atherosclerosis	0.000202	0.00486	CbGeAlD
Lamivudine—Urticaria—Pravastatin—atherosclerosis	0.000201	0.00115	CcSEcCtD
Lamivudine—Asthenia—Simvastatin—atherosclerosis	0.0002	0.00115	CcSEcCtD
Lamivudine—Diarrhoea—Ezetimibe—atherosclerosis	0.0002	0.00115	CcSEcCtD
Lamivudine—Abdominal pain—Pravastatin—atherosclerosis	0.0002	0.00115	CcSEcCtD
Lamivudine—Body temperature increased—Pravastatin—atherosclerosis	0.0002	0.00115	CcSEcCtD
Lamivudine—Pruritus—Simvastatin—atherosclerosis	0.000198	0.00113	CcSEcCtD
Lamivudine—Dizziness—Lovastatin—atherosclerosis	0.000197	0.00113	CcSEcCtD
Lamivudine—Dizziness—Ezetimibe—atherosclerosis	0.000194	0.00111	CcSEcCtD
Lamivudine—Diarrhoea—Simvastatin—atherosclerosis	0.000191	0.0011	CcSEcCtD
Lamivudine—Vomiting—Lovastatin—atherosclerosis	0.00019	0.00109	CcSEcCtD
Lamivudine—Hypersensitivity—Niacin—atherosclerosis	0.000189	0.00108	CcSEcCtD
Lamivudine—Rash—Lovastatin—atherosclerosis	0.000188	0.00108	CcSEcCtD
Lamivudine—Dermatitis—Lovastatin—atherosclerosis	0.000188	0.00108	CcSEcCtD
Lamivudine—Headache—Lovastatin—atherosclerosis	0.000187	0.00107	CcSEcCtD
Lamivudine—Vomiting—Ezetimibe—atherosclerosis	0.000186	0.00107	CcSEcCtD
Lamivudine—Hypersensitivity—Pravastatin—atherosclerosis	0.000186	0.00107	CcSEcCtD
Lamivudine—Dizziness—Simvastatin—atherosclerosis	0.000185	0.00106	CcSEcCtD
Lamivudine—Rash—Ezetimibe—atherosclerosis	0.000185	0.00106	CcSEcCtD
Lamivudine—Dermatitis—Ezetimibe—atherosclerosis	0.000184	0.00106	CcSEcCtD
Lamivudine—Asthenia—Niacin—atherosclerosis	0.000184	0.00106	CcSEcCtD
Lamivudine—Headache—Ezetimibe—atherosclerosis	0.000183	0.00105	CcSEcCtD
Lamivudine—Pruritus—Niacin—atherosclerosis	0.000181	0.00104	CcSEcCtD
Lamivudine—Asthenia—Pravastatin—atherosclerosis	0.000181	0.00104	CcSEcCtD
Lamivudine—Pruritus—Pravastatin—atherosclerosis	0.000179	0.00103	CcSEcCtD
Lamivudine—ABCB1—adipose tissue—atherosclerosis	0.000178	0.00428	CbGeAlD
Lamivudine—Vomiting—Simvastatin—atherosclerosis	0.000178	0.00102	CcSEcCtD
Lamivudine—Nausea—Lovastatin—atherosclerosis	0.000177	0.00102	CcSEcCtD
Lamivudine—Rash—Simvastatin—atherosclerosis	0.000176	0.00101	CcSEcCtD
Lamivudine—Dermatitis—Simvastatin—atherosclerosis	0.000176	0.00101	CcSEcCtD
Lamivudine—Diarrhoea—Niacin—atherosclerosis	0.000175	0.00101	CcSEcCtD
Lamivudine—Headache—Simvastatin—atherosclerosis	0.000175	0.001	CcSEcCtD
Lamivudine—Nausea—Ezetimibe—atherosclerosis	0.000174	0.000998	CcSEcCtD
Lamivudine—Diarrhoea—Pravastatin—atherosclerosis	0.000173	0.000991	CcSEcCtD
Lamivudine—Dizziness—Niacin—atherosclerosis	0.00017	0.000973	CcSEcCtD
Lamivudine—Dizziness—Pravastatin—atherosclerosis	0.000167	0.000958	CcSEcCtD
Lamivudine—Nausea—Simvastatin—atherosclerosis	0.000166	0.000952	CcSEcCtD
Lamivudine—Vomiting—Niacin—atherosclerosis	0.000163	0.000936	CcSEcCtD
Lamivudine—Rash—Niacin—atherosclerosis	0.000162	0.000928	CcSEcCtD
Lamivudine—Dermatitis—Niacin—atherosclerosis	0.000162	0.000927	CcSEcCtD
Lamivudine—Headache—Niacin—atherosclerosis	0.000161	0.000922	CcSEcCtD
Lamivudine—Vomiting—Pravastatin—atherosclerosis	0.000161	0.000921	CcSEcCtD
Lamivudine—Rash—Pravastatin—atherosclerosis	0.000159	0.000913	CcSEcCtD
Lamivudine—Dermatitis—Pravastatin—atherosclerosis	0.000159	0.000913	CcSEcCtD
Lamivudine—Headache—Pravastatin—atherosclerosis	0.000158	0.000908	CcSEcCtD
Lamivudine—Nausea—Niacin—atherosclerosis	0.000152	0.000874	CcSEcCtD
Lamivudine—Nausea—Pravastatin—atherosclerosis	0.00015	0.000861	CcSEcCtD
Lamivudine—ABCB1—liver—atherosclerosis	0.000125	0.003	CbGeAlD
Lamivudine—ABCG2—Metabolism—ALOX5—atherosclerosis	1.41e-05	0.000109	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	1.4e-05	0.000108	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—atherosclerosis	1.4e-05	0.000108	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOA5—atherosclerosis	1.4e-05	0.000108	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALOX5—atherosclerosis	1.4e-05	0.000108	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CETP—atherosclerosis	1.38e-05	0.000106	CbGpPWpGaD
Lamivudine—DCK—Metabolism—INS—atherosclerosis	1.38e-05	0.000106	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.36e-05	0.000105	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PLA2G1B—atherosclerosis	1.35e-05	0.000104	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.35e-05	0.000103	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.34e-05	0.000103	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—HMOX1—atherosclerosis	1.33e-05	0.000102	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SCARB1—atherosclerosis	1.32e-05	0.000102	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALOX5—atherosclerosis	1.3e-05	0.0001	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.29e-05	9.9e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	1.28e-05	9.87e-05	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	1.28e-05	9.83e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOB—atherosclerosis	1.27e-05	9.77e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NAMPT—atherosclerosis	1.27e-05	9.75e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—atherosclerosis	1.26e-05	9.69e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LIPC—atherosclerosis	1.26e-05	9.68e-05	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—atherosclerosis	1.26e-05	9.64e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NAMPT—atherosclerosis	1.26e-05	9.64e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.26e-05	9.64e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOC3—atherosclerosis	1.25e-05	9.62e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMGCR—atherosclerosis	1.25e-05	9.6e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LIPC—atherosclerosis	1.25e-05	9.58e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LDLR—atherosclerosis	1.25e-05	9.57e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.24e-05	9.53e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOC3—atherosclerosis	1.24e-05	9.52e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.24e-05	9.51e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTM1—atherosclerosis	1.24e-05	9.5e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LDLR—atherosclerosis	1.23e-05	9.47e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.23e-05	9.41e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—HMOX1—atherosclerosis	1.22e-05	9.37e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CETP—atherosclerosis	1.22e-05	9.34e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—LPL—atherosclerosis	1.21e-05	9.32e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—NOS3—atherosclerosis	1.21e-05	9.27e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CETP—atherosclerosis	1.2e-05	9.25e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GPX1—atherosclerosis	1.18e-05	9.1e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—atherosclerosis	1.17e-05	8.99e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NAMPT—atherosclerosis	1.17e-05	8.99e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOB—atherosclerosis	1.17e-05	8.98e-05	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—atherosclerosis	1.17e-05	8.97e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SCARB1—atherosclerosis	1.16e-05	8.95e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LIPC—atherosclerosis	1.16e-05	8.93e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOC3—atherosclerosis	1.16e-05	8.88e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CD36—atherosclerosis	1.15e-05	8.86e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SCARB1—atherosclerosis	1.15e-05	8.85e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LDLR—atherosclerosis	1.15e-05	8.82e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTM1—atherosclerosis	1.14e-05	8.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCG1—atherosclerosis	1.13e-05	8.7e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.13e-05	8.66e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CETP—atherosclerosis	1.12e-05	8.62e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—LPL—atherosclerosis	1.12e-05	8.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.11e-05	8.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCA1—atherosclerosis	1.11e-05	8.56e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK3—atherosclerosis	1.11e-05	8.51e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—atherosclerosis	1.1e-05	8.48e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMGCR—atherosclerosis	1.1e-05	8.45e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.1e-05	8.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOB—atherosclerosis	1.09e-05	8.4e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MTHFR—atherosclerosis	1.09e-05	8.4e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GPX1—atherosclerosis	1.09e-05	8.36e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMGCR—atherosclerosis	1.09e-05	8.36e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.08e-05	8.28e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—atherosclerosis	1.07e-05	8.25e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SCARB1—atherosclerosis	1.07e-05	8.25e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARA—atherosclerosis	1.07e-05	8.24e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—atherosclerosis	1.07e-05	8.2e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.07e-05	8.2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FABP4—atherosclerosis	1.06e-05	8.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LCAT—atherosclerosis	1.06e-05	8.18e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CD36—atherosclerosis	1.06e-05	8.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.05e-05	8.08e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOA4—atherosclerosis	1.04e-05	8.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—LPL—atherosclerosis	1.04e-05	8.02e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AGT—atherosclerosis	1.04e-05	7.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.03e-05	7.88e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOE—atherosclerosis	1.02e-05	7.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PRKCG—atherosclerosis	1.01e-05	7.8e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMGCR—atherosclerosis	1.01e-05	7.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.01e-05	7.77e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CAV1—atherosclerosis	1.01e-05	7.74e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOA1—atherosclerosis	1.01e-05	7.73e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MTHFR—atherosclerosis	1e-05	7.72e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.95e-06	7.64e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARA—atherosclerosis	9.85e-06	7.57e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCA1—atherosclerosis	9.8e-06	7.53e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.71e-06	7.46e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCA1—atherosclerosis	9.7e-06	7.45e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	9.57e-06	7.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMOX1—atherosclerosis	9.56e-06	7.34e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AGT—atherosclerosis	9.54e-06	7.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP27A1—atherosclerosis	9.49e-06	7.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—atherosclerosis	9.4e-06	7.22e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOE—atherosclerosis	9.35e-06	7.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	9.3e-06	7.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	9.29e-06	7.13e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CAV1—atherosclerosis	9.27e-06	7.12e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOA1—atherosclerosis	9.24e-06	7.1e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—atherosclerosis	9.18e-06	7.05e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOB—atherosclerosis	9.16e-06	7.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PDGFB—atherosclerosis	9.15e-06	7.03e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCA1—atherosclerosis	9.04e-06	6.95e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOA2—atherosclerosis	8.99e-06	6.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALOX15—atherosclerosis	8.99e-06	6.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	8.99e-06	6.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	8.99e-06	6.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—atherosclerosis	8.91e-06	6.84e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCG5—atherosclerosis	8.88e-06	6.82e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—atherosclerosis	8.86e-06	6.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOE—atherosclerosis	8.75e-06	6.72e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—LPL—atherosclerosis	8.74e-06	6.72e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—INS—atherosclerosis	8.69e-06	6.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	8.67e-06	6.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CAV1—atherosclerosis	8.67e-06	6.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOA1—atherosclerosis	8.65e-06	6.64e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LPA—atherosclerosis	8.58e-06	6.59e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GPX1—atherosclerosis	8.53e-06	6.55e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—atherosclerosis	8.44e-06	6.48e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMOX1—atherosclerosis	8.41e-06	6.46e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMOX1—atherosclerosis	8.32e-06	6.39e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BGN—atherosclerosis	8.31e-06	6.38e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CD36—atherosclerosis	8.31e-06	6.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOA5—atherosclerosis	8.22e-06	6.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—atherosclerosis	8.15e-06	6.26e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—atherosclerosis	8.15e-06	6.26e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—atherosclerosis	8.09e-06	6.21e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOB—atherosclerosis	8.06e-06	6.19e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—INS—atherosclerosis	7.99e-06	6.14e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOB—atherosclerosis	7.97e-06	6.13e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—atherosclerosis	7.97e-06	6.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	7.92e-06	6.08e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—atherosclerosis	7.87e-06	6.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.84e-06	6.03e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—atherosclerosis	7.84e-06	6.02e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMOX1—atherosclerosis	7.76e-06	5.96e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—atherosclerosis	7.76e-06	5.96e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARA—atherosclerosis	7.72e-06	5.93e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LPL—atherosclerosis	7.69e-06	5.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALOX5—atherosclerosis	7.65e-06	5.87e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NOS3—atherosclerosis	7.62e-06	5.86e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LPL—atherosclerosis	7.61e-06	5.85e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GPX1—atherosclerosis	7.5e-06	5.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AGT—atherosclerosis	7.48e-06	5.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—INS—atherosclerosis	7.47e-06	5.74e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—atherosclerosis	7.47e-06	5.74e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOB—atherosclerosis	7.43e-06	5.71e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GPX1—atherosclerosis	7.43e-06	5.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.36e-06	5.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOE—atherosclerosis	7.33e-06	5.63e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—atherosclerosis	7.32e-06	5.63e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CD36—atherosclerosis	7.31e-06	5.62e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAV1—atherosclerosis	7.26e-06	5.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOA1—atherosclerosis	7.24e-06	5.56e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CD36—atherosclerosis	7.23e-06	5.56e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—atherosclerosis	7.23e-06	5.55e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LPL—atherosclerosis	7.1e-06	5.45e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NOS3—atherosclerosis	7.01e-06	5.38e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—atherosclerosis	6.97e-06	5.36e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—atherosclerosis	6.93e-06	5.32e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GPX1—atherosclerosis	6.92e-06	5.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—atherosclerosis	6.87e-06	5.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NAMPT—atherosclerosis	6.86e-06	5.27e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—atherosclerosis	6.85e-06	5.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LIPC—atherosclerosis	6.81e-06	5.24e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARA—atherosclerosis	6.79e-06	5.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOC3—atherosclerosis	6.77e-06	5.2e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CD36—atherosclerosis	6.74e-06	5.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LDLR—atherosclerosis	6.73e-06	5.17e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARA—atherosclerosis	6.72e-06	5.17e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—atherosclerosis	6.61e-06	5.08e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AGT—atherosclerosis	6.58e-06	5.06e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CETP—atherosclerosis	6.57e-06	5.05e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS3—atherosclerosis	6.55e-06	5.04e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AGT—atherosclerosis	6.51e-06	5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.46e-06	4.96e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOE—atherosclerosis	6.45e-06	4.95e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—atherosclerosis	6.41e-06	4.92e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—atherosclerosis	6.39e-06	4.91e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAV1—atherosclerosis	6.39e-06	4.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—atherosclerosis	6.38e-06	4.9e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOE—atherosclerosis	6.38e-06	4.9e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOA1—atherosclerosis	6.37e-06	4.9e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAV1—atherosclerosis	6.32e-06	4.86e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOA1—atherosclerosis	6.31e-06	4.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SCARB1—atherosclerosis	6.3e-06	4.84e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARA—atherosclerosis	6.27e-06	4.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—INS—atherosclerosis	6.26e-06	4.81e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AGT—atherosclerosis	6.07e-06	4.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—atherosclerosis	6e-06	4.61e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOE—atherosclerosis	5.95e-06	4.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMGCR—atherosclerosis	5.95e-06	4.57e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAV1—atherosclerosis	5.89e-06	4.53e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOA1—atherosclerosis	5.88e-06	4.52e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.83e-06	4.48e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—atherosclerosis	5.82e-06	4.47e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—atherosclerosis	5.76e-06	4.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—atherosclerosis	5.74e-06	4.41e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—atherosclerosis	5.62e-06	4.31e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—atherosclerosis	5.56e-06	4.27e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—atherosclerosis	5.55e-06	4.26e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—INS—atherosclerosis	5.51e-06	4.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NOS3—atherosclerosis	5.49e-06	4.22e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—INS—atherosclerosis	5.45e-06	4.19e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—atherosclerosis	5.37e-06	4.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCA1—atherosclerosis	5.3e-06	4.07e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—atherosclerosis	5.18e-06	3.98e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—INS—atherosclerosis	5.08e-06	3.9e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—atherosclerosis	5.05e-06	3.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—atherosclerosis	5.02e-06	3.86e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—atherosclerosis	5e-06	3.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NOS3—atherosclerosis	4.83e-06	3.71e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NOS3—atherosclerosis	4.78e-06	3.67e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—atherosclerosis	4.68e-06	3.59e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—atherosclerosis	4.66e-06	3.58e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.55e-06	3.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK3—atherosclerosis	4.47e-06	3.43e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NOS3—atherosclerosis	4.46e-06	3.42e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—atherosclerosis	4.42e-06	3.39e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—atherosclerosis	4.37e-06	3.36e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOB—atherosclerosis	4.36e-06	3.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—atherosclerosis	4.33e-06	3.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—atherosclerosis	4.24e-06	3.26e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LPL—atherosclerosis	4.16e-06	3.2e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—atherosclerosis	4.08e-06	3.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX1—atherosclerosis	4.06e-06	3.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CD36—atherosclerosis	3.95e-06	3.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.74e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARA—atherosclerosis	3.67e-06	2.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AGT—atherosclerosis	3.56e-06	2.73e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—atherosclerosis	3.5e-06	2.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOE—atherosclerosis	3.49e-06	2.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAV1—atherosclerosis	3.45e-06	2.65e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOA1—atherosclerosis	3.45e-06	2.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—atherosclerosis	3.27e-06	2.51e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—atherosclerosis	3.22e-06	2.47e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.15e-06	2.42e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—atherosclerosis	3.04e-06	2.33e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—atherosclerosis	3.01e-06	2.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—INS—atherosclerosis	2.98e-06	2.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—atherosclerosis	2.73e-06	2.1e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NOS3—atherosclerosis	2.61e-06	2.01e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—atherosclerosis	2.52e-06	1.94e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.39e-06	1.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—atherosclerosis	2.22e-06	1.71e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—atherosclerosis	2.2e-06	1.69e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—atherosclerosis	2.05e-06	1.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—atherosclerosis	1.2e-06	9.22e-06	CbGpPWpGaD
